item management s discussion and analysis of financial condition and results of operations 
outlook for  the company will continue to execute on its strategic plans 
however  changing medicare rules on the eligibility of power wheelchairs for the elderly and the recent passage of the medicare prescription drug bill will temper an aggressive positioning for guidance 
as the industry approaches  when the cuts in reimbursement for nine durable medical equipment items will be implemented as provided in the medicare prescription drug bill  purchases by providers for their rental fleets may be adversely affected see business government regulation for more information on these governmental trends that are likely to impact the company s business 
in light of this likely pressure  the company believes that  in  it will have a net sales increase of between and and earnings per share of between and for results of operations versus net sales 
consolidated net sales for increased for the year  to  from  with net sales increasing in all business segments on a reported basis 
foreign currency translation accounted for of the net sales increase  while acquisitions contributed an additional 
the overall growth was primarily driven by volume increases in north america and australasia 
north american operations north american net sales  consisting of rehab power wheelchairs  custom manual wheelchairs  personal mobility and seating and positioning  standard manual wheelchairs  personal care  home care beds  low air loss therapy and patient transport  continuing care beds and furniture  respiratory oxygen concentrators  aerosol therapy  sleep  homefill and associated respiratory and distributed ostomy  incontinence  diabetic  wound care and other medical supplies products increased over the prior year  with currency translation having less than a one percentage point impact and acquisitions accounting for for the year  the net sales increase was attributable to increases in respiratory products  rehab products  distributed products and continuing care products  which were partially offset by declines in standard products 
excluding acquisitions  rehab product net sales increased by and continuing care product net sales declined by 
the net sales improvements were led by strong sales growth in oxygen concentrators  the homefill tm product line and consumer power products 
declines were primarily attributable to continued pricing pressures in standard products and weaker sales to nursing homes through invacare continuing care group as a result of the continued uncertainty surrounding government reimbursement programs 
other products  consisting primarily of the company s canadian and aftermarket parts businesses  had an net sales increase primarily as a result of volume increases 
european operations european net sales increased over the prior year to  from  adjusting for foreign currency and acquisition  european net sales decreased 
the decline was primarily due to slower than expected sales in the nordic region and reimbursement pressures in germany 
australasia operations australasian net sales increased from the prior year to  from  excluding the impact of foreign exchange  net sales increased for the year 
the increase was primarily the result of sales at dynamic controls due in part to a significant increase in sales to a non healthcare customer 
gross profit 
consolidated gross profit as a percentage of net sales was in and in margins remained relatively flat  as the company was able to offset pricing pressures with improved manufacturing performance 
north american gross profit as a percentage of net sales was in versus in the increase was primarily attributable to continued cost reduction efforts and improved product and customer mix 
gross profit in europe as a percentage of net sales improved percentage point from the prior year 
the improvement is attributable to favorable sales mix towards higher margin products and cost reduction efforts 
i gross profit in australasia as a percentage of net sales decreased by percentage points from last year 
the decline was due in part to increased sales of lower margin products in the company s dynamic controls subsidiary and increased costs to support the growth in the business 
selling  general and administrative 
consolidated selling  general and administrative expenses as a percentage of net sales were in and in the overall dollar increase was  or with currency translation increasing selling  general and administrative costs by approximately  or and acquisitions by  or 
selling  general and administrative expenses also increased as a result of accruals for management bonuses as a result of improved profitability  increased distribution and commission costs related to increased volumes  continued investments in marketing and branding programs  and increased insurance costs 
north american operations selling  general and administrative expenses increased or  compared to the increase is primarily attributable to acquisitions  continued investments in marketing and branding programs  additional provisions for bad debt and increases in insurance costs 
european operations selling  general and administrative expenses increased or  from the prior year 
european selling  general and administrative expenses were negatively impacted by foreign currency translation and acquisitions  which increased expenses  reported in dollars by  or and  or  respectively 
the remaining increase was primarily attributable to additional programs to re establish sales growth 
australasian operations selling  general and administrative expenses increased or  with foreign currency increasing the expense by  or 
australasian selling  general and administrative costs grew at a slower rate than sales principally as a result of aggressive expense control 
interest 
interest expense decreased to  in from  in  representing a decrease 
this decrease was attributable to the continued favorable interest rate environment in and to a decrease in the company s average borrowings outstanding under the company s revolving credit facility 
the company s debt to equity ratio decreased to as of december  from as of the end of the prior year 
interest income increased in to  from  in the prior year  primarily attributable to an increase in loan origination fees received from de lage landen inc dll 
since december  invacare customers primarily utilize the third party financing arrangement with dll  a subsidiary of rabo bank of the netherlands  to provide financing 
income taxes 
the company had an effective tax rate of in both and  which is lower than the united states federal statutory rate as a significant portion of the company earnings are outside of the united states and taxed at lower rates 
research and development 
the company continues to increase its research and development activities to maintain its competitive advantage 
the company dedicates dollars to applied research activities to ensure that new and enhanced design concepts are available to its businesses 
research and development expenditures  which are included in costs of products sold  increased to  in from  in the expenditures  as a percentage of net sales  were in and in the prior year 
versus net sales 
consolidated net sales for increased  to  from  for the year with net sales increasing in all business segments on a reported basis 
excluding the impact of foreign currency  north america and europe achieved sales gains of and  while australasian sales declined 
the overall growth was primarily driven by new product introductions 
north american operations north american net sales  consisting of rehab power wheelchairs  custom manual wheelchairs  scooters and seating and positioning  standard manual wheelchairs  personal care  home care beds  low air loss therapy and patient transport  continuing care beds and furniture  respiratory oxygen concentrators  aerosol therapy  sleep  homefill and associated respiratory and distributed ostomy  incontinence  diabetic  wound care and other medical supplies products grew in over  adjusting for the exit of two product lines with currency translation having no material impact 
for  net sales of rehab products increased by driven by the continued strengthening in sales of consumer power products introduced during net sales of distributed products increased by 
however  standard and respiratory product net sales were down and  respectively  or and  respectively  adjusting for the exit of two product lines 
the standard products net sales decline was primarily due to pricing pressure from low cost imports from the far east  the company s exit from the lift out chair product i line  and slow transition by customers to the new standard wheelchair product line introduced in the fourth quarter 
the decline in respiratory net sales was driven by slow purchases by national accounts and the company s exit from the liquid oxygen product line 
with reimbursement and economic uncertainty  many dealers limited their purchases of replacement products for their rental fleets in order to preserve cash 
other products  consisting primarily of the company s canadian and aftermarket parts businesses  had a net sales decrease for  primarily as a result of volume increases 
european operations european net sales improved in over  which included a positive impact from foreign currency translation 
sales growth was driven by volume increases in power wheelchairs  manual wheelchairs  high action wheelchairs  patient aids and scooters 
australasia operations net sales for the australasia group increased in from levels 
excluding the impact of foreign exchange  net sales decreased for the year 
the decrease was the result of volume declines  primarily in the company s dynamic controls subsidiary 
weak global economic conditions tend to have a more significant impact on this business than the other businesses of the company 
gross profit 
consolidated gross profit as a percentage of net sales was in and in margins remained flat in  as the company was able to offset unfavorable product mix and pricing pressures with improved manufacturing performance 
north american gross profit from operations as a percentage of net sales was in compared with in the decrease was primarily attributable to a shift towards lower margin product lines distributed  respiratory  and consumer power products and higher freight and warranty costs 
gross profit in europe as a percentage of net sales improved percentage points in from the improvement was attributable to a shift in product mix towards higher margin products  outsourcing projects that improved the european cost position and favorable currency translation 
gross profit in australasia was down by percentage points in from the decline was due principally to volume declines in core markets and an increase in mix towards lower margin products  which was partially offset by manufacturing cost reductions 
selling  general and administrative 
consolidated selling  general and administrative expenses  as a percentage of net sales  were in compared with in the overall dollar decrease was  or with currency translation increasing selling  general and administrative costs by approximately  or 
the decrease was primarily in north america as current year results were favorable to prior year as a result of a charge taken in the impact was partially offset by continued investment in marketing and branding programs being implemented to drive future growth  higher employee benefit costs  increased investment in additional headcount  additional provision for bad debts and significant increases in insurance costs largely due to general market conditions 
the non recurring and unusual charge taken in was approximately   after tax to reserve the value of certain investments and notes receivable 
the decline in value of these investments was determined to be other than temporary due in part to the economic decline and tightening of the capital markets  which made obtaining the additional funding that these entities require difficult 
north american operations selling  general and administrative expenses decreased or  compared to as noted above  the overall decrease was due to the fact that a charge was taken in  which was partially offset by an increase in marketing and branding programs  additional provision for bad debt  higher employee benefit costs and significant increases in insurance costs 
european operations selling  general and administrative expenses increased  or from european selling  general and administrative expenses were negatively impacted by foreign currency translation  which increased selling  general and administrative expenses reported in dollars by  the remaining increase was due to increased systems costs and depreciation expense 
australasia operations selling  general and administrative expenses decreased approximately from the overall dollar decline between years was  despite foreign currency increasing the expense by  the decline was due to tight expense controls 
i interest 
interest expense decreased to  in from  in  which represented a decrease 
this decrease was attributable to the reduction in borrowings outstanding under the company s revolving credit facility and also a reduction in borrowing costs due to the low interest rate environment in the company s debt to equity ratio decreased to as of december  from as of the end of the prior year 
interest income decreased in to  from  in the prior year  representing a decrease 
the decrease was a direct result of the minimal amount of new installment contracts that were written internally 
interest income primarily represents loan origination fees received from de lage landen inc dll 
since december  invacare customers primarily utilize the third party financing arrangement with dll  a subsidiary of rabo bank of the netherlands  to provide financing 
income taxes 
the company had an effective tax rate of in compared with in  excluding the effects of the unusual and non recurring charge recorded in the effective rate for including the unusual and non recurring charge was as a result of the valuation reserve recorded in the fourth quarter of  which was not entirely deductible for tax purposes due to limitations on capital losses 
the lower effective tax rate for was primarily due to the change in accounting for goodwill 
see income taxes and non recurring and unusual items in the notes to consolidated financial statements for further discussion of these items 
research and development 
the company continued to increase its research and development activities in in order to maintain its competitive advantage 
while the competitive environment required that research and development expenditures be focused on the cost reduction of products while increasing functionality and reliability  the company continued to dedicate dollars to applied research activities to ensure that new and enhanced design concepts were available to its businesses in the future 
research and development expenditures  which were included in costs of products sold  increased to  in from  in the expenditures  as a percentage of net sales  were in and in the prior year 
inflation although the company cannot determine the precise effects of inflation  management believes that inflation does continue to have an influence on the cost of materials  salaries and benefits  utilities and outside services 
the company attempts to minimize or offset the effects through increased sales volume  capital expenditure programs designed to improve productivity  alternative sourcing of material and other cost control measures 
in and  the company was able to offset the majority of the impact of price increases from suppliers by productivity improvements and other cost reduction activities 
liquidity and capital resources the company continues to maintain an adequate liquidity position through its unused bank lines of credit see long term debt in the notes to consolidated financial statements and working capital management 
the company maintains various bank lines of credit to finance its worldwide operations 
in  the company issued  in senior notes  which are due between and in  the company completed a  multi currency  long term revolving credit agreement  which expires on october  or such later dates as mutually agreed upon by the company and the banks 
additionally  the company maintains various other demand lines of credit totaling a us dollar equivalent of approximately  as of december  the lines of credit along with cash generated from operations have been and will continue to be used to fund the company s domestic and foreign working capital  capital expenditures and acquisition requirements 
as of december   the company had approximately  available under its various lines of credit  excluding debt covenant restrictions  compared to  at december  the company s borrowing arrangements contain covenants with respect to  among other items  interest coverage  net worth  dividend payments  working capital  and funded debt to capitalization  as defined in the company s bank agreements and agreement with its note holders 
the company is in compliance with all covenant requirements 
under the most restrictive covenant of the company s borrowing arrangements  the company has the capacity to borrow up to an additional  as of december   compared to  at december  while there is general concern about the potential for rising interest rates  exposure to interest rate fluctuations is manageable given that a portion of the debt is at fixed rates through in addition  the ability to utilize interest rate swaps to fix a higher percentage of the company s debt coupled with free cash flow should allow invacare to absorb the expected modest rate increases in the months ahead without any material impact on our liquidity or capital resources 
as of december   the weighted average floating interest rate on us borrowings was 
i capital expenditures there are no individually material capital expenditure commitments outstanding as of december  the company estimates that capital investments for could approximate up to  compared to actual capital expenditures of  in the company believes that its balances of cash and cash equivalents  together with funds generated from operations and existing borrowing facilities  will be sufficient to meet its operating cash requirements and fund required capital expenditures for the foreseeable future 
cash flows cash flows provided by operating activities were  in  compared to  last year 
the decrease is due primarily to increases in receivables and inventory resulting from increases in revenues  partially offset by increases in accounts payable and accrued expenses  compared to the same periods a year ago 
cash flows used for investing activities were  in  compared to  in the increase was largely due to the acquisition of four companies in in addition  purchases of property and equipment activity in was higher compared to the prior year while cash received from installment sales contracts decreased significantly due to the fact that the company no longer enters into new installment contracts as a result of its third party financing arrangement with dll 
cash flows used for financing activities in were  compared to  in financing activities for were impacted by acquisitions made during the year  for which the company borrowed funds 
however  the amounts borrowed were more than offset by payments to reduce debt 
in addition to acquisition activities  the effect of foreign currency translation results in amounts being shown in the consolidated statement of cash flows that are different from the changes reflected in the respective balance sheet captions 
contractual obligations in thousands payments due by period total less than year years years more than years long term debt obligations senior notes      revolving credit agreements    other notes  capital lease obligations    operating lease obligations     purchase obligations computer systems contracts   other long term obligations serp   product liability     other  principally deferred compensation   total      dividend policy it is the company s policy to pay a nominal dividend in order for its stock to be more attractive to a broader range of investors 
the current annual dividend rate remains at per common share and per class b common share 
it is not anticipated that this will change materially as the company continues to have available significant growth opportunities through internal development and acquisitions 
for  dividends of per common share and per class b common share were declared and paid 
non recurring and unusual items in  the company recorded a fourth quarter non cash charge of approximately   after tax to reserve the value of certain investments and notes receivable 
the decline in value of these investments was determined to be other than temporary due in part to the recent economic decline and tightening of the capital markets  which has made obtaining the additional funding that these entities require difficult 
i critical accounting policies the consolidated financial statements include accounts of the company and all majority owned subsidiaries 
the preparation of financial statements in conformity with accounting principles generally accepted in the united states requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying consolidated financial statements and related footnotes 
in preparing these financial statements  management has made its best estimates and judgments of certain amounts included in the financial statements  giving due consideration to materiality 
however  application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and  as a result  actual results could differ from these estimates 
revenue recognition invacare s revenues are recognized when products are shipped to unaffiliated customers 
the securities and exchange commission s staff accounting bulletin sab no 
 revenue recognition  as updated by sab no 
 provides guidance on the application of generally accepted accounting principles to selected revenue recognition issues 
the company has concluded that its revenue recognition policy is appropriate and in accordance with generally accepted accounting principles and sab no 
allowance for uncollectible accounts receivable accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future 
substantially all of the company s receivables are due from health care  medical equipment dealers and long term care facilities located throughout the united states  australia  canada  new zealand and europe 
a significant portion of products sold to dealers  both foreign and domestic  is ultimately funded through government reimbursement programs such as medicare and medicaid 
in addition  the company has seen a significant shift in reimbursement to customers from managed care entities 
as a consequence  changes in these programs can have an adverse impact on dealer liquidity and profitability 
the estimated allowance for uncollectible amounts is based primarily on management s evaluation of the financial condition of the customer 
in addition  as a result of the third party financing arrangement with dll  management monitors the collection status of these contracts in accordance with the company s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts 
inventories and related allowance for obsolete and excess inventory inventories are stated at the lower of cost or market with cost principally determined for domestic manufacturing inventories by the last in  first out lifo method and for non domestic inventories and domestic finished products purchased for resale by the first in  first out fifo method 
inventories have been reduced by an allowance for excess and obsolete inventories 
the estimated allowance is based on management s review of inventories on hand compared to estimated future usage and sales 
goodwill  intangible and other long lived assets property  equipment  intangibles and certain other long lived assets are amortized over their useful lives 
useful lives are based on management s estimates of the period that the assets will generate revenue 
as a result of the adoption of statement of financial accounting standard sfas no 
 goodwill and other intangible assets in  goodwill and intangible assets deemed to have indefinite lives are subject to annual impairment tests in accordance with the statement 
furthermore  goodwill and other long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable 
the company completed the required initial analysis of goodwill as of january  as well the annual impairment tests in the fourth quarter of and the results of these analyses indicated no impairment of goodwill 
product liability the company s captive insurance company  invatection insurance co  currently has a policy year that runs from september to august and insures annual policy losses of million per occurrence and million in the aggregate of the company s north american product liability exposure 
the company also has additional layers of external insurance coverage insuring million in annual aggregate losses arising from individual claims that exceed the captive insurance company policy limits 
invatection records product liability reserves based upon independent actuarial valuations 
there can be no assurance that invacare s current insurance levels will continue to be adequate or available at affordable rates 
warranty generally  the company s products are covered by warranties against defects in material and workmanship for periods up to six years from the date of sale to the customer 
certain components carry a lifetime warranty 
a provision for estimated warranty cost is recorded at the time of sale based upon actual experience 
the company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed 
see current liabilities in the notes to the consolidated financial statements for a reconciliation of the changes in the warranty accrual 
i accounting for stock based compensation the company accounts for options under its stock based compensation plans using the intrinsic value method proscribed in accounting principles board opinion apbo no 
 accounting for stock issued to employees  and related interpretations 
the majority of the options awarded have been granted at exercise prices equal to the market value of the underlying stock on the date of grant  thus  no compensation cost has been reflected in the consolidated statement of earnings for these options 
in addition  restricted stock awards have been granted without cost to the recipients and are being expensed on a straight line basis over the vesting periods 
if the company had applied the fair value recognition provisions of sfas no 
 accounting for stock based compensation  for all stock options granted  net earnings per share assuming dilution would have been reduced by in  in and in in december  the financial accounting standards board fasb issued sfas no 
 accounting for stock based compensation transition and disclosure 
this statement provides guidance for those companies wishing to voluntarily change to the fair value based method of accounting for stock based compensation 
the statement also amends the disclosure requirements of sfas no 
while invacare continues to utilize the disclosure only provisions of sfas no 
 the company has modified its disclosures to comply with the new statement 
see the company s accounting policies and shareholders equity transactions in the notes to the consolidated financial statements 
recently issued accounting pronouncements in january  the fasb issued interpretation no 
 consolidation of variable interest entities fin  which was revised in december and  which among other things  deferred the implementation date of fin until periods after march  this interpretation requires consolidation of an entity if the company is subject to a majority of the risk of loss from the variable interest entity s vie activities or entitled to receive a majority of the entity s residual returns  or both 
a company that consolidates a vie is known as the primary beneficiary of that entity 
as of december   the company had an investment in a development stage company  which is currently pursuing fda approval to market a product focused on the treatment of post stroke shoulder pain in the united states 
the amount of net advances and investment recorded on the company s books is approximately  at december  based on the provisions of fin and the company s preliminary analysis  the company does not believe that its investment is a vie 
item a 
quantitative and qualitative disclosure about market risk the company is exposed to market risk through various financial instruments  including fixed rate and floating rate debt instruments 
the company uses interest swap agreements to mitigate its exposure to interest rate fluctuations 
based on december  debt levels  a change in interest rates would impact interest expense by approximately  additionally  the company operates internationally and as a result is exposed to foreign currency fluctuations 
specifically  the exposure includes intercompany loans  and third party sales or payments 
in an attempt to reduce this exposure  foreign currency forward contracts are utilized 
the company does not believe that any potential loss related to these financial instruments would have a material adverse effect on the company s financial condition or results of operations 
private securities litigation reform act the statements contained in this form k constitute forward looking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of terms such as will  should  plan  intend  expect  continue  believe  anticipate and seek  as well as similar comments  are forward looking in nature 
actual results and events may differ significantly from those expressed or anticipated as a result of risks and uncertainties which include  but are not limited to  the following pricing pressures  the success of the company s ongoing efforts to reduce cost  increasing raw material costs  the consolidations of health care customers and competitors  government reimbursement issues including those that affect the sales of and margins on product  along with the viability of customers  the ability to design  manufacture  distribute and achieve market acceptance of new products with higher functionality and lower costs  the effect of offering customers competitive financing terms  invacare s ability to successfully identify  acquire and integrate strategic acquisition candidates  the difficulties in managing and operating businesses in many different foreign jurisdictions  the timely completion of facility consolidations  the vagaries of any litigation or regulatory investigations that the company may be or become involved in at any time  the difficulties in acquiring and maintaining a proprietary intellectual property ownership position  the overall economic  market and industry growth conditions including  the impact that acts of terrorism may have on such growth conditions  foreign currency and interest rate risks  invacare s ability to improve financing terms and reduce working capital  as well as the risks described from time to time in invacare s reports as filed with the securities and exchange commission 
we undertake no obligation to review or update these forward looking statements or other information contained herein 
i 
